The GDF5 rs143383 polymorphism is associated with osteoarthritis of the knee with genome-wide statistical significance

Osteoarthritis of the knee is a major cause of pain, disability and the use of healthcare resources among middle-aged and older people.1 Although osteoarthritis is multifactorial, it is known to have a significant genetic contribution and a number of studies have attempted to dissect such a contribution (see Valdes and Spector2 for review). The GDF5 gene encodes the growth differentiation factor 5, a bone morphogenetic protein involved in joint formation, expressed in different joint structures, which has been shown to ameliorate tendon, ligament and bone healing after trauma in mice.3 4 A promoter polymorphism (rs143383) in GDF5 has been found to be strongly associated with both hip and knee osteoarthritis in Asian individuals,4 and is the most widely replicated genetic association with knee osteoarthritis, although much less so for hip and hand osteoarthritis.5 This variant is functional, with the lower gene expression variant having increased genetic risk.4 A large-scale meta-analysis reported the association of the major (T) allele with knee osteoarthritis achieved OR 1.15 p=9.7×10−7 and achieved p=9×10−5 (OR 1.13, 95% CI 1.06 to 1.20) when Asian subjects were excluded.5 The genome-wide statistical significance level of p<5×10−8 is increasingly …

[1]  T. Spector,et al.  A meta-analysis of interleukin-6 promoter polymorphisms on risk of hip and knee osteoarthritis. , 2010, Osteoarthritis and cartilage.

[2]  Bjarni V. Halldórsson,et al.  A genome-wide association study identifies an osteoarthritis susceptibility locus on chromosome 7q22. , 2010, Arthritis and rheumatism.

[3]  T. Spector,et al.  The clinical relevance of genetic susceptibility to osteoarthritis. , 2010, Best practice & research. Clinical rheumatology.

[4]  D. Maraganore,et al.  Non‐replication of association for six polymorphisms from meta‐analysis of genome‐wide association studies of Parkinson's disease: Large‐scale collaborative study , 2009, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

[5]  Bjarni V. Halldórsson,et al.  A Genome-Wide Association Study Identifies an Osteoarthritis Susceptibility Locus on Chromosome 7 q 22 , 2010 .

[6]  Bjarni V. Halldórsson,et al.  Large-scale analysis of association between GDF5 and FRZB variants and osteoarthritis of the hip, knee, and hand. , 2009, Arthritis and rheumatism.

[7]  T. Spector,et al.  Association of the DVWA and GDF5 polymorphisms with osteoarthritis in UK populations , 2008, Annals of the rheumatic diseases.

[8]  Monique M. B. Breteler,et al.  The Rotterdam Study: 2016 objectives and design update , 2015, European Journal of Epidemiology.

[9]  Yusuke Nakamura,et al.  A functional polymorphism in the 5′ UTR of GDF5 is associated with susceptibility to osteoarthritis , 2007, Nature Genetics.

[10]  P. Dieppe,et al.  Pathogenesis and management of pain in osteoarthritis , 2005, The Lancet.

[11]  Borjana Mikic,et al.  Multiple Effects of GDF-5 Deficiency on Skeletal Tissues: Implications for Therapeutic Bioengineering , 2004, Annals of Biomedical Engineering.